| Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer’s disease E Zuccarello, E Acquarone, E Calcagno, EK Argyrousi, SX Deng, ... Biochemical pharmacology 176, 113818, 2020 | 75 | 2020 |
| Memory-enhancing effects of GEBR-32a, a new PDE4D inhibitor holding promise for the treatment of Alzheimer’s disease R Ricciarelli, C Brullo, J Prickaerts, O Arancio, C Villa, C Rebosio, ... Scientific reports 7 (1), 46320, 2017 | 72 | 2017 |
| Synaptic and memory dysfunction induced by tau oligomers is rescued by up-regulation of the nitric oxide cascade E Acquarone, EK Argyrousi, M Van Den Berg, W Gulisano, M Fà, ... Molecular neurodegeneration 14, 1-19, 2019 | 54 | 2019 |
| Role of cyclic nucleotides and their downstream signaling cascades in memory function: Being at the right time at the right spot EK Argyrousi, PRA Heckman, J Prickaerts Neuroscience & Biobehavioral Reviews 113, 12-38, 2020 | 45 | 2020 |
| Tau is not necessary for amyloid-β–induced synaptic and memory impairments D Puzzo, EK Argyrousi, A Staniszewski, H Zhang, E Calcagno, ... The Journal of clinical investigation 130 (9), 4831-4844, 2020 | 40 | 2020 |
| Pro-cognitive effect of upregulating cyclic guanosine monophosphate signalling during memory acquisition or early consolidation is mediated by increased AMPA receptor trafficking EK Argyrousi, PRA Heckman, BTJ van Hagen, H Muysers, ... Journal of Psychopharmacology 34 (1), 103-114, 2020 | 19 | 2020 |
| Heart failure-induced cognitive dysfunction is mediated by intracellular Ca2+ leak through ryanodine receptor type 2 H Dridi, Y Liu, S Reiken, X Liu, EK Argyrousi, Q Yuan, MC Miotto, ... Nature Neuroscience 26 (8), 1365-1378, 2023 | 17 | 2023 |
| Soluble guanylate cyclase stimulator vericiguat enhances long-term memory in rats without altering cerebral blood volume E Nelissen, EK Argyrousi, NP Van Goethem, F Zhao, CDG Hines, ... Biomedicines 9 (8), 1047, 2021 | 14 | 2021 |
| Effects of DNA methyltransferase inhibition on pattern separation performance in mice EK Argyrousi, L de Nijs, DC Lagatta, A Schlütter, MT Weidner, J Zöller, ... Neurobiology of Learning and Memory 159, 6-15, 2019 | 9 | 2019 |
| Physiological and pathological processes of synaptic plasticity and memory in drug discovery: do not forget the dose-response curve J Prickaerts, NP Van Goethem, W Gulisano, EK Argyrousi, A Palmeri, ... European journal of pharmacology 817, 59-70, 2017 | 9 | 2017 |
| Soluble guanylate cyclase stimulator riociguat improves spatial memory in mice via peripheral mechanisms E Nelissen, BTJ van Hagen, EK Argyrousi, NP van Goethem, ... Neuroscience Letters 788, 136840, 2022 | 6 | 2022 |
| Preparation of tau oligomers after the protein extraction from bacteria and brain cortices EK Argyrousi, A Staniszewski, RE Nicholls, O Arancio Amyloid Proteins: Methods and Protocols, 85-97, 2018 | 5 | 2018 |
| Mitovesicles secreted into the extracellular space of brains with mitochondrial dysfunction impair synaptic plasticity P D’Acunzo, EK Argyrousi, JM Ungania, Y Kim, S DeRosa, M Pawlik, ... Molecular Neurodegeneration 19 (1), 34, 2024 | 3 | 2024 |
| Glutamate Signalling in Object Novelty Recognition Memory Tests EK Argyrousi, PRA Heckman, J Prickaerts Handbook of Behavioral Neuroscience 27, 541-551, 2018 | 2 | 2018 |
| The 5HT2b Receptor in Alzheimer’s Disease: Increased Levels in Patient Brains and Antagonist Attenuation of Amyloid and Tau Induced Dysfunction E Acquarone, EK Argyrousi, O Arancio, DM Watterson, SM Roy Journal of Alzheimer's Disease, 1-12, 2024 | 1 | 2024 |
| Re-Arranging the Puzzle between the Amyloid-Beta and Tau Pathology: An APP-Centric Approach F Haut, EK Argyrousi, O Arancio International Journal of Molecular Sciences 25 (1), 259, 2023 | 1 | 2023 |
| Electrophysiological effects of mitochondria‐derived extracellular vesicles: implications for memory dysfunction in neurodegenerative disorders P D'Acunzo, EK Argyrousi, JM Ungania, Y Kim, S DeRosa, M Pawlik, ... Alzheimer's & Dementia 19, e076549, 2023 | 1 | 2023 |
| Nitrinergic Signalling in Object Novelty Recognition EK Argyrousi, J Prickaerts Handbook of Behavioral Neuroscience 27, 561-565, 2018 | 1 | 2018 |
| The ketamine metabolite (2R,6R)-hydroxynorketamine rescues hippocampal mRNA translation, synaptic plasticity and memory in mouse models of Alzheimer’s … D Cozachenco, FC Ribeiro, EK Argyrousi, A Staniszewski, S Wiebe, ... Alzheimer's Association International Conference, 2024 | | 2024 |
| Nonfibrillar Dutch mutant amyloid beta (Aß) aggregates (oligomers) are associated with aging-related synaptic dysfunction SE Gandy, EL Castranio, M Varghese, EK Argyrousi, K Tripathi, ... Alzheimer's Association International Conference, 2024 | | 2024 |
